These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Implications of the changing face of Clostridium difficile disease for health care practitioners. McFarland LV, Beneda HW, Clarridge JE, Raugi GJ. Am J Infect Control; 2007 May; 35(4):237-53. PubMed ID: 17482995 [Abstract] [Full Text] [Related]
29. [Clostridium difficile ribotype 027, toxinotype III in The Netherlands]. Kuijper EJ, Debast SB, Van Kregten E, Vaessen N, Notermans DW, van den Broek PJ. Ned Tijdschr Geneeskd; 2005 Sep 17; 149(38):2087-9. PubMed ID: 16201596 [Abstract] [Full Text] [Related]
30. New views on Clostridium difficile infections: Introduction. Rodloff A, Gould I. Int J Antimicrob Agents; 2009 Mar 17; 33 Suppl 1():S1. PubMed ID: 19303561 [No Abstract] [Full Text] [Related]